Detalhe da pesquisa
1.
Fully synthetic platform to rapidly generate tetravalent bispecific nanobody-based immunoglobulins.
Proc Natl Acad Sci U S A
; 120(24): e2216612120, 2023 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37276407
2.
Antigen pressure from two founder viruses induces multiple insertions at a single antibody position to generate broadly neutralizing HIV antibodies.
PLoS Pathog
; 19(6): e1011416, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37384622
3.
A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 Delta variant.
PLoS Pathog
; 18(4): e1010465, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35482816
4.
Vaccine priming of rare HIV broadly neutralizing antibody precursors in nonhuman primates.
Science
; 384(6697): eadj8321, 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38753769
5.
Broadening a SARS-CoV-1-neutralizing antibody for potent SARS-CoV-2 neutralization through directed evolution.
Sci Signal
; 16(798): eabk3516, 2023 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37582161
6.
Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape pathways.
iScience
; 25(9): 104914, 2022 Sep 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35971553
7.
Molecular insights into antibody-mediated protection against the prototypic simian immunodeficiency virus.
Nat Commun
; 13(1): 5236, 2022 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36068229
8.
One-shot identification of SARS-CoV-2 S RBD escape mutants using yeast screening.
bioRxiv
; 2021 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33758848
9.
One-shot identification of SARS-CoV-2 S RBD escape mutants using yeast screening.
Cell Rep
; 36(9): 109627, 2021 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34416153
10.
A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection.
Cell Host Microbe
; 29(5): 806-818.e6, 2021 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33894127